
Sign up to save your podcasts
Or


It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.

91,297 Listeners

21,954 Listeners

43,687 Listeners

91 Listeners

6,467 Listeners

113,121 Listeners

5 Listeners

56,944 Listeners

0 Listeners

10,331 Listeners

33 Listeners

3,051 Listeners

8,238 Listeners

29,272 Listeners

1,598 Listeners

4,294 Listeners

7 Listeners

632 Listeners

12,559 Listeners